What is AZTA's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 1.65B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for AZTA?

P/E (TTM) is n/a and 52-week range is $15.93 to $46.41 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s AZTA figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for AZTA?

The company profile lists revenue (TTM) near $624M, net income (TTM) near $-12.51B, EPS (TTM) near $-2.66 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Azenta Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Burlington, Massachusetts, US, 46.1M shares outstanding, ISIN US1143401024 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Azenta Inc

$AZTA

Health Care · Life Sciences Tools & Services

IR Run Scenarios

$37.72

+4.78%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company is headquartered in Burlington, Massachusetts and currently employs 3,000 full-time employees. The firm provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The firm's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The firm's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The firm's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.

Employees

3,000

Website

www.azenta.com/

IPO

1995-02-02

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)